Rochester Medicine Magazine: "RNA Ready"
- lindsayvicars
- Mar 31
- 1 min read
Updated: Apr 2
RNA, long overlooked in the research world, is having its moment.
The pandemic provided the rocket fuel, because mRNA vaccines essentially saved our way of life. Talk of RNA-based treatments and trials is suddenly commonplace.
Both the 2023 and 2024 Nobel Prizes In physiology or medicine were awarded for research in RNA (ribonucleic acid). The Advanced Research Projects Agency for Health (ARPA-H), a new $2 billion federal entity funding transformative ideas for health breakthroughs, focused its first multi-million-dollar grant on the development of mRNA technologies that strengthen the immune system to better fight cancer and other diseases. In 2022, more than $1 billion in private equity funds was invested in biotechnology start-ups to explore frontiers in RNA research. There are now more than 400 RNA-based drugs in development. (click here to keep reading)
Author: Emily Boynton
Comentários